{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:10:07Z","timestamp":1748934607394,"version":"3.41.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan","award":["ONC-BRCA-002"],"award-info":[{"award-number":["ONC-BRCA-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10549-025-07724-4","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T12:44:33Z","timestamp":1747745073000},"page":"291-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting the likelihood of carrying BRCA1 or BRCA2 pathogenic variants in high-risk Pakistani breast cancer patients"],"prefix":"10.1007","volume":"212","author":[{"given":"Shumaila","family":"Arif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon Hong","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humaira","family":"Naeemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqas","family":"Sami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weang Kee","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Usman","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"7724_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA A Cancer J Clinicians"},{"key":"7724_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105:812\u2013822. https:\/\/doi.org\/10.1093\/jnci\/djt095","journal-title":"J Natl Cancer Inst"},{"key":"7724_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/nejmra1503523","volume":"374","author":"LC Hartmann","year":"2016","unstructured":"Hartmann LC, Lindor NM (2016) The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med 374:454\u2013468. https:\/\/doi.org\/10.1056\/nejmra1503523","journal-title":"N Engl J Med"},{"key":"7724_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, Jervis S, Van Leeuwen FE, Milne RL, Andrieu N (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"7724_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101017","author":"W-K Ho","year":"2024","unstructured":"Ho W-K, Hassan NT, Yoon S-Y, Yang X, Lim JM, Ishak NDB, Ho PJ, Wijaya EA, Ng PP-S, Luccarini C (2024) Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants\u2013an Asian study of 572 families. Lancet Reg Health West Pac. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101017","journal-title":"Lancet Reg Health West Pac"},{"key":"7724_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41416-018-0127-5","volume":"119","author":"NM Tung","year":"2018","unstructured":"Tung NM, Garber JE (2018) BRCA1\/2 testing: therapeutic implications for breast cancer management. Br J Cancer 119:141\u2013152. https:\/\/doi.org\/10.1038\/s41416-018-0127-5","journal-title":"Br J Cancer"},{"key":"7724_CR7","doi-asserted-by":"publisher","first-page":"e194428","DOI":"10.1001\/jamanetworkopen.2019.4428","volume":"2","author":"Z Kemp","year":"2019","unstructured":"Kemp Z, Turnbull A, Yost S, Seal S, Mahamdallie S, Poyastro-Pearson E, Warren-Perry M, Eccleston A, Tan M-M, Teo SH (2019) Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open 2:e194428\u2013e194428. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.4428","journal-title":"JAMA Netw Open"},{"key":"7724_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1200\/jco.19.02190","volume":"38","author":"S Yadav","year":"2020","unstructured":"Yadav S, Hu C, Hart SN, Boddicker N, Polley EC, Na J, Gnanaolivu R, Lee KY, Lindstrom T, Armasu S, Fitz-Gibbon P, Ghosh K, Stan DL, Pruthi S, Neal L, Sandhu N, Rhodes DJ, Klassen C, Peethambaram PP, Haddad TC, Olson JE, Hoskin TL, Goetz MP, Domchek SM, Boughey JC, Ruddy KJ, Couch FJ (2020) Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer. J Clin Oncol 38:1409\u20131418. https:\/\/doi.org\/10.1200\/jco.19.02190","journal-title":"J Clin Oncol"},{"key":"7724_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s44276-024-00099-x","volume":"2","author":"HJ Pederson","year":"2024","unstructured":"Pederson HJ, Narod SA (2024) Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancer. BJC Rep 2:73. https:\/\/doi.org\/10.1038\/s44276-024-00099-x","journal-title":"BJC Rep"},{"key":"7724_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000441714","volume":"19","author":"S Nakamura","year":"2016","unstructured":"Nakamura S, Kwong A, Kim S-W, Iau P, Patmasiriwat P, Dofitas R, Aryandono T, Hu Z, Huang C-S, Ginsburg O (2016) Current status of the management of hereditary breast and ovarian cancer in Asia: first report by the Asian BRCA consortium. Public Health Genom 19:53\u201360. https:\/\/doi.org\/10.1159\/000441714","journal-title":"Public Health Genom"},{"key":"7724_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-017-4247-z","volume":"164","author":"JA Cintolo-Gonzalez","year":"2017","unstructured":"Cintolo-Gonzalez JA, Braun D, Blackford AL, Mazzola E, Acar A, Plichta JK, Griffin M, Hughes KS (2017) Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. Breast Cancer Res Treat 164:263\u2013284. https:\/\/doi.org\/10.1007\/s10549-017-4247-z","journal-title":"Breast Cancer Res Treat"},{"key":"7724_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10549-014-2987-6","volume":"145","author":"AG Arnold","year":"2014","unstructured":"Arnold AG, Otegbeye E, Fleischut MH, Glogowski EA, Siegel B, Boyar SR, Salo-Mullen E, Amoroso K, Sheehan M, Berliner JL (2014) Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families. Breast Cancer Res Treat 145:625\u2013634. https:\/\/doi.org\/10.1007\/s10549-014-2987-6","journal-title":"Breast Cancer Res Treat"},{"key":"7724_CR13","doi-asserted-by":"publisher","first-page":"8536","DOI":"10.1038\/s41598-023-35755-8","volume":"13","author":"NB M\u00f8ller","year":"2023","unstructured":"M\u00f8ller NB, Boonen DS, Feldner ES, Hao Q, Larsen M, L\u00e6nkholm A-V, Borg \u00c5, Kvist A, T\u00f6rngren T, Jensen UB (2023) Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes. Sci Rep 13:8536. https:\/\/doi.org\/10.1038\/s41598-023-35755-8","journal-title":"Sci Rep"},{"key":"7724_CR14","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1038\/s41598-019-46707-6","volume":"9","author":"F-H Hung","year":"2019","unstructured":"Hung F-H, Wang YA, Jian J-W, Peng H-P, Hsieh L-L, Hung C-F, Yang MM, Yang A-S (2019) Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan. Sci Rep 9:10229. https:\/\/doi.org\/10.1038\/s41598-019-46707-6","journal-title":"Sci Rep"},{"key":"7724_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr2118","volume":"10","author":"E Thirthagiri","year":"2008","unstructured":"Thirthagiri E, Lee S, Kang P, Lee D, Toh G, Selamat S, Yoon S, Taib NM, Thong M, Yip C (2008) Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res 10:1\u201312. https:\/\/doi.org\/10.1186\/bcr2118","journal-title":"Breast Cancer Res"},{"key":"7724_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s00268-011-1406-y","volume":"36","author":"A Kwong","year":"2012","unstructured":"Kwong A, Wong CH, Suen DT, Co M, Kurian AW, West DW, Ford JM (2012) Accuracy of BRCA1\/2 mutation prediction models for different ethnicities and genders: experience in a southern Chinese cohort. World J Surg 36:702\u2013713. https:\/\/doi.org\/10.1007\/s00268-011-1406-y","journal-title":"World J Surg"},{"key":"7724_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/jhg.2015.164","volume":"61","author":"E Kang","year":"2016","unstructured":"Kang E, Park SK, Lee JW, Kim Z, Noh W-C, Jung Y, Yang J-H, Jung SH, Kim S-W (2016) KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Hum Genet 61:365\u2013371. https:\/\/doi.org\/10.1038\/jhg.2015.164","journal-title":"J Hum Genet"},{"key":"7724_CR18","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1200\/jco.21.01647","volume":"40","author":"BH Ang","year":"2022","unstructured":"Ang BH, Ho WK, Wijaya E, Kwan PY, Ng PS, Yoon SY, Hasan SN, Lim JM, Hassan T, Tai M-C (2022) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation in Asian patients with breast cancer. J Clin Oncol 40:1542\u20131551. https:\/\/doi.org\/10.1200\/jco.21.01647","journal-title":"J Clin Oncol"},{"key":"7724_CR19","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1002\/ijc.22269","volume":"119","author":"MU Rashid","year":"2006","unstructured":"Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori AR, Seidel-Renkert A, Farooq H, Narod S (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 119:2832\u20132839. https:\/\/doi.org\/10.1002\/ijc.22269","journal-title":"Int J Cancer"},{"key":"7724_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13053-019-0125-5","volume":"17","author":"MU Rashid","year":"2019","unstructured":"Rashid MU, Muhammad N, Naeemi H, Khan FA, Hassan M, Faisal S, Gull S, Amin A, Loya A, Hamann U (2019) Spectrum and prevalence of BRCA1\/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study. Hered Cancer Clini Pract 17:1\u201313. https:\/\/doi.org\/10.1186\/s13053-019-0125-5","journal-title":"Hered Cancer Clini Pract"},{"key":"7724_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-016-4044-0","volume":"161","author":"MU Rashid","year":"2017","unstructured":"Rashid MU, Muhammad N, Amin A, Loya A, Hamann U (2017) Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast\/ovarian cancer in Pakistan. Breast Cancer Res Treat 161:191\u2013201. https:\/\/doi.org\/10.1007\/s10549-016-4044-0","journal-title":"Breast Cancer Res Treat"},{"key":"7724_CR22","volume-title":"Statistical analysis with missing data","author":"RJ Little","year":"2019","unstructured":"Little RJ, Rubin DB (2019) Statistical analysis with missing data. John Wiley & Sons, Hoboken"},{"key":"7724_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29\u201336. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747","journal-title":"Radiology"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07724-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:39:21Z","timestamp":1748932761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7724"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07724-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board (IRB) of Shaukat Khanum Memorial Cancer Hospital and Research Centre (IRB approval numbers Date: June 01, 2001\/No. ONC-BRCA-001 and Date: May 05, 2006\/No. ONC-BRCA-002).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}